{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:19:58Z","timestamp":1793387998825,"version":"4.5.0"},"reference-count":379,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.cbi.2022.110194","type":"journal-article","created":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T02:10:04Z","timestamp":1664590204000},"page":"110194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"special_numbering":"C","title":["Anticancer peptides mechanisms, simple and complex"],"prefix":"10.1016","volume":"368","author":[{"given":"Peiman","family":"Norouzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Mirmohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hassan","family":"Houshdar Tehrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2022.110194_bib1","article-title":"Cancer treatment using peptides: current therapies and future prospects","volume":"2012","author":"Thundimadathil","year":"2012","journal-title":"J.\u00a0Amino Acids"},{"issue":"7","key":"10.1016\/j.cbi.2022.110194_bib2","first-page":"3565","article-title":"Biomimetic peptides for the treatment of cancer","volume":"36","author":"Mine","year":"2016","journal-title":"Anticancer Res."},{"key":"10.1016\/j.cbi.2022.110194_bib3","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2174\/1389203719666180111150008","article-title":"The potential use of peptides in cancer treatment","volume":"19 8","author":"Yavari","year":"2018","journal-title":"Curr. Protein Pept. Sci."},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib4","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/cbdd.12055","article-title":"The future of peptide-based drugs","volume":"81","author":"Craik","year":"2013","journal-title":"Chem. Biol. Drug Des."},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12929-017-0328-x","article-title":"Evaluation of the use of therapeutic peptides for cancer treatment","volume":"24","author":"Marqus","year":"2017","journal-title":"J.\u00a0Biomed. Sci."},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00726-010-0511-9","article-title":"The effect of acidic residues and amphipathicity on the lytic activities of mastoparan peptides studied by fluorescence and CD spectroscopy","volume":"40","author":"Leite","year":"2011","journal-title":"Amino Acids"},{"issue":"17","key":"10.1016\/j.cbi.2022.110194_bib7","doi-asserted-by":"crossref","first-page":"10805","DOI":"10.1021\/la202608r","article-title":"New insight into the mechanism of action of wasp mastoparan peptides: lytic activity and clustering observed with giant vesicles","volume":"27","author":"dos Santos Cabrera","year":"2011","journal-title":"Langmuir"},{"key":"10.1016\/j.cbi.2022.110194_bib8","doi-asserted-by":"crossref","unstructured":"de la Torre BG, Albericio F. Peptide Therapeutics 2.0. Molecules. 2020.","DOI":"10.3390\/molecules25102293"},{"issue":"5","key":"10.1016\/j.cbi.2022.110194_bib9","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/med.21312","article-title":"Peptide-based proteasome inhibitors in anticancer drug design","volume":"34","author":"Micale","year":"2014","journal-title":"Med. Res. Rev."},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1158\/0008-5472.CAN-20-2199","article-title":"Rafting down the metastatic cascade: the role of lipid rafts in cancer metastasis, cell death, and clinical outcomes","volume":"81","author":"Greenlee","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.cbi.2022.110194_bib11","volume":"vol. 5","author":"Yao","year":"2014"},{"key":"10.1016\/j.cbi.2022.110194_bib12","series-title":"Challenge S. Infections in Leukemia","author":"Chandran","year":"2012"},{"issue":"4","key":"10.1016\/j.cbi.2022.110194_bib13","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.cell.2020.10.027","article-title":"Persistent cancer cells: the deadly survivors","volume":"183","author":"Shen","year":"2020","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.cbi.2022.110194_bib14","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"cell"},{"key":"10.1016\/j.cbi.2022.110194_bib15","first-page":"2539","article-title":"Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect","volume":"9","author":"Nehoff","year":"2014","journal-title":"Int. J. Nanomed."},{"issue":"8","key":"10.1016\/j.cbi.2022.110194_bib16","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2174\/1381612822666151214104941","article-title":"Glioma: tryptophan catabolite and melatoninergic pathways link microRNA, 14-3-3, chromosome 4q35, epigenetic processes and other glioma biochemical changes","volume":"22","author":"Beischlag","year":"2016","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.cbi.2022.110194_bib17","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/B978-0-323-46143-6.00010-5","article-title":"Redox activated polymeric nanoparticles in tumor therapy","author":"Alimoradi","year":"2017","journal-title":"Nanostructures for Drug Delivery"},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ctrv.2010.05.001","article-title":"The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by tumor-vascular disrupting agents","volume":"37","author":"Siemann","year":"2011","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.cbi.2022.110194_bib19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jbiomech.2018.03.036","article-title":"Cell penetrating peptide modulation of membrane biomechanics by Molecular dynamics","volume":"73","author":"Grasso","year":"2018","journal-title":"J.\u00a0Biomech."},{"key":"10.1016\/j.cbi.2022.110194_bib20","series-title":"Channels, Carriers, and Pumps: an Introduction to Membrane Transport","author":"Stein","year":"2014"},{"issue":"6","key":"10.1016\/j.cbi.2022.110194_bib21","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.bbamem.2014.01.027","article-title":"Regulation of the cancer cell membrane lipid composition by NaCHOleate: effects on cell signaling and therapeutical relevance in glioma","volume":"1838","author":"Llad\u00f3","year":"2014","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.cbi.2022.110194_bib22","series-title":"Pediatric Critical Care E-Book","author":"Fuhrman","year":"2011"},{"key":"10.1016\/j.cbi.2022.110194_bib23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1874-5245(97)80006-7","article-title":"The role of phospholipids in cell function","volume":"2","author":"Dowhan","year":"1997","journal-title":"Advances in Lipobiology"},{"key":"10.1016\/j.cbi.2022.110194_bib24","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/0006-3002(63)90793-5","article-title":"The role of lipids in mitochondrial electron transfer and oxidative phosphorylation","volume":"70","author":"Green","year":"1963","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cbi.2022.110194_bib25","series-title":"The Cell: a Molecular Approach","author":"Cooper","year":"2007"},{"key":"10.1016\/j.cbi.2022.110194_bib26","series-title":"Pharmaceutical Nanotechnology: Brief Perspective on Lipid Drug Delivery and its Current Scenario. Biomedical Applications of Nanoparticles","first-page":"91","author":"Siram","year":"2019"},{"issue":"19","key":"10.1016\/j.cbi.2022.110194_bib27","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.2174\/1381612043383971","article-title":"Membrane disrupting lytic peptides for cancer treatments","volume":"10","author":"Leuschner","year":"2004","journal-title":"Curr. Pharmaceut. Des."},{"issue":"5497","key":"10.1016\/j.cbi.2022.110194_bib28","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1126\/science.290.5497.1721","article-title":"How cells handle cholesterol","volume":"290","author":"Simons","year":"2000","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.cbi.2022.110194_bib29","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s10863-020-09846-4","article-title":"Lipid composition of the cancer cell membrane","volume":"52","author":"Szlasa","year":"2020","journal-title":"J.\u00a0Bioenerg. Biomembr."},{"key":"10.1016\/j.cbi.2022.110194_bib30","series-title":"The Membranes of Cells","author":"Yeagle","year":"2016"},{"key":"10.1016\/j.cbi.2022.110194_bib31","series-title":"Plant Growth and Development","first-page":"197","article-title":"5 - characteristics of plant cells that are important in development","author":"Fosket","year":"1994"},{"key":"10.1016\/j.cbi.2022.110194_bib32","series-title":"Membrane Proteins an Introduction to Biological Membranes","author":"Stillwell","year":"2016"},{"key":"10.1016\/j.cbi.2022.110194_bib33","series-title":"Comprehensive Biotechnology","first-page":"615","article-title":"1.46 - effects of shear stress on cells","author":"McCloskey","year":"2011"},{"issue":"2","key":"10.1016\/j.cbi.2022.110194_bib34","doi-asserted-by":"crossref","first-page":"251a","DOI":"10.1016\/j.bpj.2012.11.1412","article-title":"Structure of glycocalyx","volume":"104","author":"Monne","year":"2013","journal-title":"Biophys. J."},{"key":"10.1016\/j.cbi.2022.110194_bib35","series-title":"Transport in Biological Media","first-page":"1","article-title":"Chapter 1 - modeling momentum and mass transport in cellular biological media: from the molecular to the tissue scale","author":"Kapellos","year":"2013"},{"issue":"8","key":"10.1016\/j.cbi.2022.110194_bib36","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.bbamem.2008.09.013","article-title":"Control of cell selectivity of antimicrobial peptides","volume":"1788","author":"Matsuzaki","year":"2009","journal-title":"Biochim. Biophys. Acta Biomembr."},{"issue":"2","key":"10.1016\/j.cbi.2022.110194_bib37","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijantimicag.2008.04.003","article-title":"Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp","volume":"32","author":"Chou","year":"2008","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"12","key":"10.1016\/j.cbi.2022.110194_bib38","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/nbt1267","article-title":"Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies","volume":"24","author":"Hancock","year":"2006","journal-title":"Nat. Biotechnol."},{"issue":"6","key":"10.1016\/j.cbi.2022.110194_bib39","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/j.1420-9101.2005.00925.x","article-title":"Molecular evolution of animal antimicrobial peptides: widespread moderate positive selection","volume":"18","author":"Tennessen","year":"2005","journal-title":"J.\u00a0Evol. Biol."},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep02984","article-title":"In silico models for designing and discovering novel anticancer peptides","volume":"3","author":"Tyagi","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2022.110194_bib41","first-page":"107","article-title":"Cholesterol lowering in cancer prevention and therapy","author":"Huang","year":"2016","journal-title":"Cholesterol Lowering Therapies and Drugs"},{"key":"10.1016\/j.cbi.2022.110194_bib42","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ctrv.2016.10.008","article-title":"Cell membrane modulation as adjuvant in cancer therapy","volume":"52","author":"Zalba","year":"2017","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.cbi.2022.110194_bib43","series-title":"Inflammatory and Oxidative Stress Markers in Skeletal Muscle of Obese Subjects","first-page":"163","author":"Catal\u00e1n","year":"2018"},{"key":"10.1016\/j.cbi.2022.110194_bib44","series-title":"Encyclopedia of Biological Chemistry","first-page":"76","article-title":"Sphingolipid biosynthesis","author":"Leipelt","year":"2004"},{"issue":"5","key":"10.1016\/j.cbi.2022.110194_bib45","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1177\/096120339600500531","article-title":"Regulatory mechanisms in maintenance and modulation of transmembrane lipid asymmetry: pathophysiological implications","volume":"5","author":"Bevers","year":"1996","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.cbi.2022.110194_bib46","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.bbamem.2007.11.008","article-title":"Studies on anticancer activities of antimicrobial peptides","volume":"1778","author":"Hoskin","year":"2008","journal-title":"Biochim. Biophys. Acta Biomembr."},{"issue":"8","key":"10.1016\/j.cbi.2022.110194_bib47","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.chemphyslip.2011.09.004","article-title":"Membrane-active host defense peptides\u2013challenges and perspectives for the development of novel anticancer drugs","volume":"164","author":"Riedl","year":"2011","journal-title":"Chem. Phys. Lipids"},{"issue":"20","key":"10.1016\/j.cbi.2022.110194_bib48","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1007\/s00018-017-2604-z","article-title":"Tumor cell membrane-targeting cationic antimicrobial peptides: novel insights into mechanisms of action and therapeutic prospects","volume":"74","author":"Baxter","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib49","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/nar\/24.1.248","article-title":"A\u00a0revised database of O-glycosylated proteins","volume":"24","author":"Hansen","year":"1996","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cbi.2022.110194_bib50","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3389\/fmicb.2013.00294","article-title":"From antimicrobial to anticancer peptides","volume":"4","author":"Gaspar","year":"2013","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.cbi.2022.110194_bib51","volume":"vol. 2012","author":"Kolter","year":"2012"},{"issue":"3","key":"10.1016\/j.cbi.2022.110194_bib52","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0304-4165(00)00079-9","article-title":"Distribution of sulfated glycosaminoglycans in the animal kingdom: widespread occurrence of heparin-like compounds in invertebrates","volume":"1475","author":"Medeiros","year":"2000","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"1\u20133","key":"10.1016\/j.cbi.2022.110194_bib53","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejphar.2009.08.043","article-title":"Cationic amphiphilic peptides with cancer-selective toxicity","volume":"625","author":"Schweizer","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2022.110194_bib54","first-page":"43","article-title":"In search of new targets-the membrane lipid phosphatidylserine-the underestimated Achilles' Heel of cancer cells","volume":"22","author":"Zweytick","year":"2011","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib55","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s41048-018-0080-0","article-title":"Detection of cancer cells based on glycolytic-regulated surface electrical charges","volume":"5","author":"Le","year":"2019","journal-title":"Biophysics Reports"},{"issue":"11","key":"10.1016\/j.cbi.2022.110194_bib56","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.7150\/thno.16358","article-title":"Targeting negative surface charges of cancer cells by multifunctional nanoprobes","volume":"6","author":"Chen","year":"2016","journal-title":"Theranostics"},{"issue":"21","key":"10.1016\/j.cbi.2022.110194_bib57","doi-asserted-by":"crossref","first-page":"5275","DOI":"10.3390\/cancers13215275","article-title":"Dual targeting with cell surface electrical charge and folic acid via superparamagnetic Fe3O4@ Cu2\u2013xS for photothermal cancer cell killing","volume":"13","author":"Deng","year":"2021","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.cbi.2022.110194_bib58","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1517\/13543784.15.8.933","article-title":"Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment","volume":"15","author":"Mader","year":"2006","journal-title":"Expet Opin. Invest. Drugs"},{"issue":"3","key":"10.1016\/j.cbi.2022.110194_bib59","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1158\/1535-7163.MCT-10-0811","article-title":"Studies on mechanism of action of anticancer peptides by modulation of hydrophobicity within a defined structural framework","volume":"10","author":"Huang","year":"2011","journal-title":"Mol. Cancer Therapeut."},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib60","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0022-2836(82)90515-0","article-title":"A\u00a0simple method for displaying the hydropathic character of a protein","volume":"157","author":"Kyte","year":"1982","journal-title":"J.\u00a0Mol. Biol."},{"issue":"2","key":"10.1016\/j.cbi.2022.110194_bib61","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nbt1190","article-title":"Screening for peptide drugs from the natural repertoire of biodiverse protein folds","volume":"24","author":"Watt","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cbi.2022.110194_bib62","series-title":"Amino Acids and Peptides: Building Blocks for Skin Proteins","first-page":"287","author":"Noguchi","year":"2009"},{"key":"10.1016\/j.cbi.2022.110194_bib63","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.foodchem.2017.10.087","article-title":"Immunomodulatory and anticancer protein hydrolysates (peptides) from food proteins: a review","volume":"245","author":"Chalamaiah","year":"2018","journal-title":"Food Chem."},{"key":"10.1016\/j.cbi.2022.110194_bib64","article-title":"A\u00a0review of the design and modification of lactoferricins and their derivatives","volume":"26","author":"Wang","year":"2013","journal-title":"Biometals"},{"key":"10.1016\/j.cbi.2022.110194_bib65","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/B978-0-12-416687-5.00004-X","article-title":"Chapter 4-Three-dimensional structure of proteins and disorders of protein misfolding","author":"Bhagavan","year":"2015","journal-title":"Essentials Med. Biochem."},{"key":"10.1016\/j.cbi.2022.110194_bib66","series-title":"Biochemistry, Primary Protein Structure","author":"Sanvictores","year":"2020"},{"key":"10.1016\/j.cbi.2022.110194_bib67","series-title":"Molecular Biology of the Cell","author":"Alberts","year":"2008"},{"issue":"4","key":"10.1016\/j.cbi.2022.110194_bib68","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1073\/pnas.37.4.205","article-title":"The structure of proteins: two hydrogen-bonded helical configurations of the polypeptide chain","volume":"37","author":"Pauling","year":"1951","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib69","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1021\/ci400541d","article-title":"Dihedral-based segment identification and classification of biopolymers I: proteins","volume":"54","author":"Nagy","year":"2014","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.cbi.2022.110194_bib70","series-title":"Biochemistry","author":"Berg","year":"2002"},{"key":"10.1016\/j.cbi.2022.110194_bib71","first-page":"1","article-title":"Design and preparation of biomimetic and bioinspired materials","author":"Leiro","year":"2017","journal-title":"Bioinspired Mater. Med. Appl."},{"key":"10.1016\/j.cbi.2022.110194_bib72","series-title":"Comprehensive Biotechnology","first-page":"3","article-title":"1.02 - amino acid metabolism","author":"Newsholme","year":"2011"},{"key":"10.1016\/j.cbi.2022.110194_bib73","series-title":"Encyclopedia of Analytical Science","first-page":"344","article-title":"PROTEINS | overview","author":"Skipper","year":"2005"},{"issue":"22","key":"10.1016\/j.cbi.2022.110194_bib74","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1111\/febs.13507","article-title":"Dissecting \u03c0-helices: sequence, structure and function","volume":"282","author":"Kumar","year":"2015","journal-title":"FEBS J."},{"key":"10.1016\/j.cbi.2022.110194_bib75","series-title":"Encyclopedia of Analytical Science","author":"Worsfold","year":"2019"},{"issue":"3","key":"10.1016\/j.cbi.2022.110194_bib76","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0022-2836(88)90641-9","article-title":"Helix geometry in proteins","volume":"201","author":"Barlow","year":"1988","journal-title":"J.\u00a0Mol. Biol."},{"issue":"12","key":"10.1016\/j.cbi.2022.110194_bib77","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1021\/bi00012a001","article-title":"Views of helical peptides: a proposal for the position of 310-helix along the thermodynamic folding pathway","volume":"34","author":"Millhauser","year":"1995","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.cbi.2022.110194_bib78","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jmb.2010.09.034","article-title":"Evolutionary origin of a secondary structure: \u03c0-helices as cryptic but widespread insertional variations of \u03b1-helices that enhance protein functionality","volume":"404","author":"Cooley","year":"2010","journal-title":"J.\u00a0Mol. Biol."},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib79","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1110\/ps.9.1.201","article-title":"The \u03c0-helix translates structure into function","volume":"9","author":"Weaver","year":"2000","journal-title":"Protein Sci."},{"key":"10.1016\/j.cbi.2022.110194_bib80","series-title":"Encyclopedia of Bioinformatics and Computational Biology: ABC of Bioinformatics","author":"Ranganathan","year":"2018"},{"key":"10.1016\/j.cbi.2022.110194_bib81","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/B978-0-08-055294-1.00063-5","article-title":"Self-assembling biomaterials","author":"Rudra","year":"2011","journal-title":"Comprehensive Biomaterials"},{"key":"10.1016\/j.cbi.2022.110194_bib82","series-title":"Encyclopedia of Physical Science and Technology","first-page":"191","article-title":"Protein structure","author":"Rayment","year":"2003"},{"key":"10.1016\/j.cbi.2022.110194_bib83","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/B978-0-12-416596-0.00007-5","article-title":"Structure and orientation of interfacial proteins determined by sum frequency generation vibrational spectroscopy: method and application","volume":"93","author":"Ye","year":"2013","journal-title":"Adv Protein Chem. Structural Biol."},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep33191","article-title":"Extension of the classical classification of \u03b2-turns","volume":"6","author":"De Brevern","year":"2016","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.cbi.2022.110194_bib85","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/bip.20960","article-title":"Roles of beta-turns in protein folding: from peptide models to protein engineering","volume":"89","author":"Marcelino","year":"2008","journal-title":"Biopolymers"},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib86","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0006-3495(98)77529-0","article-title":"A\u00a0helix propensity scale based on experimental studies of peptides and proteins","volume":"75","author":"Pace","year":"1998","journal-title":"Biophys. J."},{"issue":"5","key":"10.1016\/j.cbi.2022.110194_bib87","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1073\/pnas.052706099","article-title":"Natural \u03b2-sheet proteins use negative design to avoid edge-to-edge aggregation","volume":"99","author":"Richardson","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5238","key":"10.1016\/j.cbi.2022.110194_bib88","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1126\/science.270.5238.980","article-title":"Guidelines for protein design: the energetics of \u03b2 sheet side chain interactions","volume":"270","author":"Smith","year":"1995","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.cbi.2022.110194_bib89","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1021\/ar9601048","article-title":"Construction and design of \u03b2-sheets","volume":"30","author":"Smith","year":"1997","journal-title":"Acc. Chem. Res."},{"issue":"3","key":"10.1016\/j.cbi.2022.110194_bib90","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/prot.340150303","article-title":"\u03b2VI turns in peptides and proteins: a model peptide mimicry","volume":"15","author":"M\u00fcller","year":"1993","journal-title":"Proteins: Struct., Funct., Bioinf."},{"issue":"2","key":"10.1016\/j.cbi.2022.110194_bib91","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.3390\/molecules18022307","article-title":"3-Substituted prolines: from synthesis to structural applications, from peptides to foldamers","volume":"18","author":"Mothes","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2022.110194_bib92","doi-asserted-by":"crossref","unstructured":"Godbey WjaitbWP, Cambridge. (Chapter 2)\u2014Proteins. 2014:9-33.","DOI":"10.1016\/B978-1-907568-28-2.00002-2"},{"key":"10.1016\/j.cbi.2022.110194_bib93","series-title":"Textbook of Veterinary Physiological Chemistry","first-page":"18","article-title":"Chapter 4 - protein structure","author":"Engelking","year":"2015"},{"key":"10.1016\/j.cbi.2022.110194_bib94","series-title":"Quantitative Human Physiology: an Introduction","author":"Feher","year":"2017"},{"key":"10.1016\/j.cbi.2022.110194_bib95","series-title":"Principles of Organic Chemistry","author":"Ouellette","year":"2015"},{"key":"10.1016\/j.cbi.2022.110194_bib96","series-title":"Organic Chemistry","first-page":"1","article-title":"1 - structure and bonding in organic compounds","author":"Ouellette","year":"2014"},{"key":"10.1016\/j.cbi.2022.110194_bib97","series-title":"Pharmacology","first-page":"11","article-title":"Chapter 3 - bonds found in biological chemistry","author":"Aldred","year":"2009"},{"issue":"3","key":"10.1016\/j.cbi.2022.110194_bib98","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/s13361-011-0317-3","article-title":"Fast and selective modification of thiol proteins\/peptides by N-(phenylseleno) phthalimide","volume":"23","author":"Wang","year":"2012","journal-title":"J.\u00a0Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.cbi.2022.110194_bib99","series-title":"Biology and Engineering of Stem Cell Niches","first-page":"195","article-title":"Chapter 13 - matrix chemistry controlling stem cell behavior","author":"Klecker","year":"2017"},{"issue":"11","key":"10.1016\/j.cbi.2022.110194_bib100","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1089\/ars.2009.2466","article-title":"Protein disulfide isomerase: a critical evaluation of its function in disulfide bond formation","volume":"11","author":"Hatahet","year":"2009","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.cbi.2022.110194_bib101","series-title":"Essentials of Medical Biochemistry : with Clinical Cases","author":"Bhagavan","year":"2015"},{"key":"10.1016\/j.cbi.2022.110194_bib102","series-title":"Modern Physical Organic Chemistry","author":"Anslyn","year":"2006"},{"key":"10.1016\/j.cbi.2022.110194_bib103","series-title":"Introduction to Nanoscience","author":"Lindsay","year":"2010"},{"key":"10.1016\/j.cbi.2022.110194_bib104","series-title":"Encyclopedia of Analytical Science","first-page":"302","article-title":"Geochemistry | soil, major inorganic components","author":"van der Jagt","year":"2019"},{"issue":"3","key":"10.1016\/j.cbi.2022.110194_bib105","first-page":"898","article-title":"Salt bridges: geometrically specific, designable interactions. Proteins: structure, Function","volume":"79","author":"Donald","year":"2011","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cbi.2022.110194_bib106","series-title":"The Organic Chemistry of Drug Design and Drug Action","article-title":"Chapter 3 - receptors","author":"Silverman","year":"2004"},{"key":"10.1016\/j.cbi.2022.110194_bib107","author":"Atkins","year":"2011","journal-title":"Phys. Chem. Life Sci."},{"key":"10.1016\/j.cbi.2022.110194_bib108","series-title":"Physical Chemistry for the Biosciences","author":"Chang","year":"2005"},{"issue":"4711","key":"10.1016\/j.cbi.2022.110194_bib109","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/185422a0","article-title":"Structure of myoglobin: a three-dimensional Fourier synthesis at 2 A. resolution","volume":"185","author":"Jc","year":"1960","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2022.110194_bib110","author":"Page"},{"key":"10.1016\/j.cbi.2022.110194_bib112","first-page":"53","article-title":"Chapter 4-biophysical principles","author":"Pollard","year":"2017","journal-title":"Cell Biol."},{"key":"10.1016\/j.cbi.2022.110194_bib113","series-title":"The Practice of Medicinal Chemistry","first-page":"359","article-title":"Chapter 14 - the role of functional groups in drug\u2013receptor interactions","author":"Schaeffer","year":"2008"},{"key":"10.1016\/j.cbi.2022.110194_bib114","series-title":"Encyclopedia of Materials: Science and Technology","first-page":"1","article-title":"Surface and colloid chemistry","author":"Adair","year":"2001"},{"issue":"10","key":"10.1016\/j.cbi.2022.110194_bib115","doi-asserted-by":"crossref","first-page":"12773","DOI":"10.3390\/ijms131012773","article-title":"Theoretical models for surface forces and adhesion and their measurement using atomic force microscopy","volume":"13","author":"Leite","year":"2012","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.cbi.2022.110194_bib116","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.molmed.2012.04.012","article-title":"Cell-penetrating peptides: breaking through to the other side","volume":"18","author":"Koren","year":"2012","journal-title":"Trends Mol. Med."},{"issue":"8","key":"10.1016\/j.cbi.2022.110194_bib117","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/sj.bjp.0706279","article-title":"Characterisation of cell-penetrating peptide-mediated peptide delivery","volume":"145","author":"Jones","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cbi.2022.110194_bib118","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.00697","article-title":"Cell-penetrating peptides in diagnosis and treatment of human diseases: from preclinical research to clinical application","volume":"11","author":"Xie","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cbi.2022.110194_bib119","article-title":"Mechanisms of cellular uptake of cell-penetrating peptides","volume":"2011","author":"Madani","year":"2011","journal-title":"J. Biophys."},{"issue":"9","key":"10.1016\/j.cbi.2022.110194_bib120","article-title":"Inverted micelle formation of cell-penetrating peptide studied by coarse-grained simulation: importance of attractive force between cell-penetrating peptides and lipid head group","volume":"134","author":"Kawamoto","year":"2011","journal-title":"J.\u00a0Chem. Phys."},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib121","first-page":"59","article-title":"Templated assembly of pore-forming peptides in lipid membranes","volume":"73","author":"Unwin","year":"2019","journal-title":"Chimia"},{"key":"10.1016\/j.cbi.2022.110194_bib122","series-title":"An Introduction to Biological Membranes","first-page":"423","article-title":"Chapter 19 - membrane transport","author":"Stillwell","year":"2016"},{"key":"10.1016\/j.cbi.2022.110194_bib123","series-title":"Encyclopedia of Biological Chemistry","first-page":"197","article-title":"Endocytosis","author":"Donaldson","year":"2013"},{"key":"10.1016\/j.cbi.2022.110194_bib124","series-title":"An Introduction to Biological Membranes: Composition, Structure and Function","author":"Stillwell","year":"2016"},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145617","article-title":"Phospholipid scramblase 1 modulates FcR-mediated phagocytosis in differentiated macrophages","volume":"11","author":"Herate","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2022.110194_bib126","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/bs.pmbts.2016.03.002","article-title":"Chapter six - the ubiquitin network in the control of EGFR endocytosis and signaling","volume":"141","author":"Conte","year":"2016","journal-title":"Progress Molecular Biol.Translat. Science"},{"key":"10.1016\/j.cbi.2022.110194_bib127","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/B978-012369417-1\/50054-7","article-title":"Equilibrative and concentrative transport mechanisms","author":"Preusch","year":"2007","journal-title":"Princ. Clinical Pharmacol."},{"key":"10.1016\/j.cbi.2022.110194_bib128","series-title":"Physiologic Factors Related to Drug Absorption. Dosage Form Design Considerations","first-page":"117","author":"Acharya","year":"2018"},{"key":"10.1016\/j.cbi.2022.110194_bib130","series-title":"Fermented Foods in Health and Disease Prevention","first-page":"23","article-title":"Chapter 2 - bioactive peptides in fermented foods: production and evidence for health effects","author":"Martinez-Villaluenga","year":"2017"},{"key":"10.1016\/j.cbi.2022.110194_bib131","series-title":"Encyclopedia of Food Chemistry","first-page":"381","article-title":"Bioactive peptides","author":"Mora","year":"2019"},{"key":"10.1016\/j.cbi.2022.110194_bib132","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.csbj.2015.11.005","article-title":"Prediction of anticancer peptides against MCF-7 breast cancer cells from the peptidomes of Achatina fulica mucus fractions","volume":"14","author":"Teerasak","year":"2016","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"22","key":"10.1016\/j.cbi.2022.110194_bib133","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.2174\/092986712801661004","article-title":"The use of therapeutic peptides to target and to kill cancer cells","volume":"19","author":"Boohaker","year":"2012","journal-title":"Curr. Med. Chem."},{"issue":"10","key":"10.1016\/j.cbi.2022.110194_bib134","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1517\/17425240903143745","article-title":"Therapeutic peptides for cancer therapy. Part I\u2013peptide inhibitors of signal transduction cascades","volume":"6","author":"Bidwell","year":"2009","journal-title":"Expet Opin. Drug Deliv."},{"issue":"10","key":"10.1016\/j.cbi.2022.110194_bib135","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1517\/17425240903158909","article-title":"Therapeutic peptides for cancer therapy. Part II\u2013cell cycle inhibitory peptides and apoptosis-inducing peptides","volume":"6","author":"Raucher","year":"2009","journal-title":"Expet Opin. Drug Deliv."},{"issue":"33","key":"10.1016\/j.cbi.2022.110194_bib136","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1038\/onc.2009.170","article-title":"Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms","volume":"28","author":"Satyanarayana","year":"2009","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.cbi.2022.110194_bib137","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006080","article-title":"Cell death signaling","volume":"7","author":"Green","year":"2015","journal-title":"Cold Spring Harbor Perspect. Biol."},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib138","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drudis.2014.10.003","article-title":"Peptide therapeutics: current status and future directions","volume":"20","author":"Fosgerau","year":"2015","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.cbi.2022.110194_bib139","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3892\/ijo.2020.5099","article-title":"Anticancer peptide: physicochemical property, functional aspect and trend in clinical application","volume":"57","author":"Chiangjong","year":"2020","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib140","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/med.20252","article-title":"On the selectivity and efficacy of defense peptides with respect to cancer cells","volume":"33","author":"Harris","year":"2013","journal-title":"Med. Res. Rev."},{"issue":"11","key":"10.1016\/j.cbi.2022.110194_bib141","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/psc.717","article-title":"Current strategies for the development of peptide-based anti-cancer therapeutics","volume":"11","author":"Borghouts","year":"2005","journal-title":"J.\u00a0Pept. Sci."},{"issue":"3","key":"10.1016\/j.cbi.2022.110194_bib142","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s10989-019-09946-9","article-title":"Antimicrobial peptides (AMPs): roles, functions and mechanism of action","volume":"26","author":"Seyfi","year":"2020","journal-title":"Int. J. Pept. Res. Therapeut."},{"key":"10.1016\/j.cbi.2022.110194_bib143","series-title":"Anticancer Peptides: Prospective Innovation in Cancer Therapy. Host Defense Peptides and their Potential as Therapeutic Agents","first-page":"95","author":"Gaspar","year":"2016"},{"issue":"14","key":"10.1016\/j.cbi.2022.110194_bib144","doi-asserted-by":"crossref","first-page":"6210","DOI":"10.1021\/ja210569f","article-title":"Anticancer \u03b2-hairpin peptides: membrane-induced folding triggers activity","volume":"134","author":"Sinthuvanich","year":"2012","journal-title":"J.\u00a0Am. Chem. Soc."},{"issue":"6","key":"10.1016\/j.cbi.2022.110194_bib145","article-title":"Anti-tumour effects of antimicrobial peptides, components of the innate immune system, against haematopoietic tumours in Drosophila mxc mutants","volume":"12","author":"Araki","year":"2019","journal-title":"Disease Models Mechan."},{"issue":"3","key":"10.1016\/j.cbi.2022.110194_bib146","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.bbamem.2012.12.015","article-title":"Molecular simulations suggest how a branched antimicrobial peptide perturbs a bacterial membrane and enhances permeability","volume":"1828","author":"Li","year":"2013","journal-title":"Biochim. Biophys. Acta Biomembr."},{"issue":"4","key":"10.1016\/j.cbi.2022.110194_bib147","first-page":"19","article-title":"A\u00a0review of potential anticancers from antimicrobial peptides","volume":"7","author":"Mohd","year":"2015","journal-title":"Int. J. Pharm. Pharmaceut. Sci."},{"issue":"9","key":"10.1016\/j.cbi.2022.110194_bib148","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tibtech.2011.05.001","article-title":"The expanding scope of antimicrobial peptide structures and their modes of action","volume":"29","author":"Stotz","year":"2011","journal-title":"Trends Biotechnol."},{"issue":"10","key":"10.1016\/j.cbi.2022.110194_bib149","doi-asserted-by":"crossref","first-page":"7560","DOI":"10.1039\/C7NJ04709F","article-title":"Antimicrobial peptide\u2013metal ion interactions\u2013a potential way of activity enhancement","volume":"42","author":"\u0141oboda","year":"2018","journal-title":"New J. Chem."},{"issue":"10","key":"10.1016\/j.cbi.2022.110194_bib150","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1021\/cb1001558","article-title":"Describing the mechanism of antimicrobial peptide action with the interfacial activity model","volume":"5","author":"Wimley","year":"2010","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.cbi.2022.110194_bib151","doi-asserted-by":"crossref","first-page":"6038","DOI":"10.26717\/BJSTR.2018.07.001536","article-title":"The antimicrobial peptides: ready for clinical trials","volume":"7","author":"Naafs","year":"2018","journal-title":"Biomed. J. Scientific Techn. Res."},{"issue":"10","key":"10.1016\/j.cbi.2022.110194_bib152","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.1158\/0008-5472.CAN-05-4569","article-title":"Inhibition of tumor growth and elimination of multiple metastases in human prostate and breast xenografts by systemic inoculation of a host defense\u2013like lytic peptide","volume":"66","author":"Papo","year":"2006","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.cbi.2022.110194_bib153","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/bip.20917","article-title":"Membrane interactions of designed cationic antimicrobial peptides: the two thresholds","volume":"89","author":"Glukhov","year":"2008","journal-title":"Biopolymers: Original Res. Biomol."},{"issue":"2","key":"10.1016\/j.cbi.2022.110194_bib154","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3892\/or.2017.5778","article-title":"Anticancer potential of bioactive peptides from animal sources","volume":"38","author":"Wang","year":"2017","journal-title":"Oncol. Rep."},{"issue":"2","key":"10.1016\/j.cbi.2022.110194_bib155","first-page":"635","article-title":"Mode of action of anticancer peptides (ACPs) from amphibian origin","volume":"35","author":"Oelkrug","year":"2015","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib156","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12934-022-01848-8","article-title":"The dual interaction of antimicrobial peptides on bacteria and cancer cells; mechanism of action and therapeutic strategies of nanostructures","volume":"21","author":"Parchebafi","year":"2022","journal-title":"Microb. Cell Factories"},{"issue":"5","key":"10.1016\/j.cbi.2022.110194_bib157","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/psc.2729","article-title":"The SMART model: soft membranes adapt and respond, also transiently, in the presence of antimicrobial peptides","volume":"21","author":"Bechinger","year":"2015","journal-title":"J.\u00a0Pept. Sci."},{"issue":"12","key":"10.1016\/j.cbi.2022.110194_bib158","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.3390\/molecules25122850","article-title":"Antimicrobial peptides as anticancer agents: functional properties and biological activities","volume":"25","author":"Tornesello","year":"2020","journal-title":"Molecules"},{"issue":"1\u20132","key":"10.1016\/j.cbi.2022.110194_bib159","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0005-2736(99)00205-9","article-title":"The structure, dynamics and orientation of antimicrobial peptides in membranes by multidimensional solid-state NMR spectroscopy","volume":"1462","author":"Bechinger","year":"1999","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.cbi.2022.110194_bib160","series-title":"Fibroblast Growth Factors","first-page":"477","article-title":"Chapter 8 - bioengineering of FGFs and new drug developments","author":"Li","year":"2018"},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib161","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.canlet.2014.05.002","article-title":"Peptide-based cancer therapy: opportunity and challenge","volume":"351","author":"Wu","year":"2014","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.cbi.2022.110194_bib162","first-page":"222","article-title":"Angiogenesis inhibitors: current strategies and future prospects","volume":"60","author":"Cook","year":"2010","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.cbi.2022.110194_bib163","article-title":"Peptide-based treatment: a promising cancer therapy","volume":"2015","author":"Xiao","year":"2015","journal-title":"J.\u00a0Immunol. Res."},{"issue":"2","key":"10.1016\/j.cbi.2022.110194_bib164","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1023\/B:AGEN.0000011730.94233.06","article-title":"Discovery and development of anti-angiogenic peptides: a structural link","volume":"6","author":"Dings","year":"2003","journal-title":"Angiogenesis"},{"issue":"6","key":"10.1016\/j.cbi.2022.110194_bib165","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jnutbio.2009.03.005","article-title":"Effect of arginine on angiogenesis induced by human colon cancer: in\u00a0vitro and in\u00a0vivo studies","volume":"21","author":"Yeh","year":"2010","journal-title":"J.\u00a0Nutr. Biochem."},{"issue":"7\u20138","key":"10.1016\/j.cbi.2022.110194_bib166","first-page":"353","article-title":"Proangiogenic factors: vascular-endothelial growth factor (VEGF) and basic fibroblast growth factor--the characteristics and function","volume":"65","author":"Mizia-Malarz","year":"2008","journal-title":"Przegl. Lek."},{"issue":"6","key":"10.1016\/j.cbi.2022.110194_bib167","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/0092-8674(91)90033-U","article-title":"Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma","volume":"66","author":"Kandel","year":"1991","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.cbi.2022.110194_bib168","first-page":"445","article-title":"Elimination of up to 80% of human pancreatic adenocarcinomas in athymic mice by cardiac hormones","volume":"21","author":"Vesely","year":"2007","journal-title":"Vivo"},{"key":"10.1016\/j.cbi.2022.110194_bib169","first-page":"527","article-title":"The logic of anti-angiogenic gene therapy","volume":"36","author":"Folkman","year":"1999","journal-title":"Cold Spring Harb. Monogr. Ser."},{"issue":"10","key":"10.1016\/j.cbi.2022.110194_bib170","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrc905","article-title":"Clinical translation of angiogenesis inhibitors","volume":"2","author":"Kerbel","year":"2002","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.cbi.2022.110194_bib171","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrd2115","article-title":"Angiogenesis: an organizing principle for drug discovery?","volume":"6","author":"Folkman","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"issue":"24","key":"10.1016\/j.cbi.2022.110194_bib172","first-page":"8890","article-title":"Combined therapy with direct and indirect angiogenesis inhibition results in enhanced antiangiogenic and antitumor effects","volume":"63","author":"Abdollahi","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.cbi.2022.110194_bib173","first-page":"833","article-title":"Antitumor and anti-angiogenic activity of Ganoderma lucidum polysaccharides peptide","volume":"25","author":"Cao","year":"2004","journal-title":"Acta Pharmacol. Sin."},{"issue":"4","key":"10.1016\/j.cbi.2022.110194_bib174","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jmb.2005.12.006","article-title":"The anti-angiogenic peptide anginex disrupts the cell membrane","volume":"356","author":"Pilch","year":"2006","journal-title":"J.\u00a0Mol. Biol."},{"issue":"7","key":"10.1016\/j.cbi.2022.110194_bib175","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.tem.2004.07.002","article-title":"Chemotherapy targeted to cancers through tumoral hormone receptors","volume":"15","author":"Schally","year":"2004","journal-title":"Trends in Endocrinology Metabolism"},{"issue":"5","key":"10.1016\/j.cbi.2022.110194_bib176","first-page":"860","article-title":"Targeting breast and prostate cancers through their hormone receptors","volume":"73","author":"Leuschner","year":"2005","journal-title":"Curr. Pharmaceut. Des."},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib177","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000108758","article-title":"Angiotensin-(1\u20137) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats","volume":"28","author":"Benter","year":"2008","journal-title":"Am. J. Nephrol."},{"issue":"6","key":"10.1016\/j.cbi.2022.110194_bib178","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1111\/j.1476-5381.2012.01905.x","article-title":"Angiotensin-(1\u20137) inhibits allergic inflammation, via the MAS1 receptor, through suppression of ERK1\/2-and NF-\u03baB-dependent pathways","volume":"166","author":"El-Hashim","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"21","key":"10.1016\/j.cbi.2022.110194_bib179","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.2174\/0929867321666140205133357","article-title":"Angiotensin-(1-7): a peptide hormone with anti-cancer activity","volume":"21","author":"Gallagher","year":"2014","journal-title":"Curr. Med. Chem."},{"issue":"4","key":"10.1016\/j.cbi.2022.110194_bib180","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0002-9440(10)64071-0","article-title":"Growth hormone receptor is expressed in human breast cancer","volume":"158","author":"Gebre-Medhin","year":"2001","journal-title":"Am. J. Pathol."},{"issue":"1\u20132","key":"10.1016\/j.cbi.2022.110194_bib181","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.gene.2010.04.016","article-title":"The evolution of somatostatin in vertebrates","volume":"463","author":"Liu","year":"2010","journal-title":"Gene"},{"key":"10.1016\/j.cbi.2022.110194_bib182","series-title":"xPharm: the Comprehensive Pharmacology Reference","first-page":"1","article-title":"SST-2 somatostatin receptor","author":"Hoyer","year":"2007"},{"issue":"4","key":"10.1016\/j.cbi.2022.110194_bib183","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1124\/pr.117.015388","article-title":"International Union of Basic and Clinical Pharmacology. CV. Somatostatin receptors: structure, function, ligands, and new nomenclature","volume":"70","author":"G\u00fcnther","year":"2018","journal-title":"Pharmacol. Rev."},{"issue":"5","key":"10.1016\/j.cbi.2022.110194_bib184","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.3390\/ijms21051682","article-title":"Somatostatin analogs in clinical practice: a review","volume":"21","author":"Gomes-Porras","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.cbi.2022.110194_bib185","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/aps.2011.170","article-title":"Structure and mechanism for recognition of peptide hormones by Class B G-protein-coupled receptors","volume":"33","author":"Pal","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"issue":"3","key":"10.1016\/j.cbi.2022.110194_bib186","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0304-4157(99)00006-4","article-title":"Modelling G-protein-coupled receptors for drug design","volume":"1422","author":"Flower","year":"1999","journal-title":"Biochim. Biophys. Acta Rev. Biomembr."},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib187","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1517\/17425240903418410","article-title":"Receptor-mediated tumor targeting based on peptide hormones","volume":"7","author":"Mez\u0151","year":"2010","journal-title":"Expet Opin. Drug Deliv."},{"issue":"7","key":"10.1016\/j.cbi.2022.110194_bib188","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/0092-8674(89)90045-7","article-title":"The p53 proto-oncogene can act as a suppressor of transformation","volume":"57","author":"Finlay","year":"1989","journal-title":"Cell"},{"issue":"26","key":"10.1016\/j.cbi.2022.110194_bib189","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003993","article-title":"Role of p53 isoforms and aggregations in cancer","volume":"95","author":"Kim","year":"2016","journal-title":"Medicine"},{"issue":"18","key":"10.1016\/j.cbi.2022.110194_bib190","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1002\/j.1460-2075.1995.tb00123.x","article-title":"Negative feedback regulation of wild-type p53 biosynthesis","volume":"14","author":"Mosner","year":"1995","journal-title":"EMBO J."},{"key":"10.1016\/j.cbi.2022.110194_bib191","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.2147\/OTT.S154337","article-title":"Peptide SA12 inhibits proliferation of breast cancer cell lines MCF-7 and MDA-MB-231 through G0\/G1 phase cell cycle arrest","volume":"11","author":"Yang","year":"2018","journal-title":"OncoTargets Ther."},{"issue":"2","key":"10.1016\/j.cbi.2022.110194_bib192","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/ijc.24725","article-title":"Inhibition of ovarian cancer cell proliferation by a cell cycle inhibitory peptide fused to a thermally responsive polypeptide carrier","volume":"126","author":"Massodi","year":"2010","journal-title":"Int. J. Cancer"},{"issue":"22","key":"10.1016\/j.cbi.2022.110194_bib193","doi-asserted-by":"crossref","first-page":"6901","DOI":"10.1158\/1078-0432.CCR-09-0484","article-title":"Intratumoral expression of mature human neutrophil peptide-1 mediates antitumor immunity in mice","volume":"15","author":"Wang","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.cbi.2022.110194_bib194","doi-asserted-by":"crossref","first-page":"e2134","DOI":"10.1038\/cddis.2016.47","article-title":"The oncolytic peptide LTX-315 triggers immunogenic cell death","volume":"7","author":"Zhou","year":"2016","journal-title":"Cell Death Dis."},{"issue":"6835","key":"10.1016\/j.cbi.2022.110194_bib195","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/35077241","article-title":"The microenvironment of the tumour\u2013host interface","volume":"411","author":"Liotta","year":"2001","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.cbi.2022.110194_bib196","doi-asserted-by":"crossref","DOI":"10.4161\/onci.25961","article-title":"Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy","volume":"2","author":"Devaud","year":"2013","journal-title":"OncoImmunology"},{"issue":"3","key":"10.1016\/j.cbi.2022.110194_bib197","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/mnfr.200900073","article-title":"Lunasin, with an arginine\u2013glycine\u2013aspartic acid motif, causes apoptosis to L1210 leukemia cells by activation of caspase-3","volume":"54","author":"Gonzalez de Mejia","year":"2010","journal-title":"Mol. Nutr. Food Res."},{"issue":"2","key":"10.1016\/j.cbi.2022.110194_bib198","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.peptides.2008.11.002","article-title":"A\u00a0novel seed peptide for cancer prevention","volume":"30","author":"Hernandez-Ledesma","year":"2009","journal-title":"Peptides"},{"issue":"7","key":"10.1016\/j.cbi.2022.110194_bib199","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/mnfr.201000632","article-title":"Relationship between lunasin's sequence and its inhibitory activity of histones H3 and H4 acetylation","volume":"55","author":"Hern\u00e1ndez-Ledesma","year":"2011","journal-title":"Mol. Nutr. Food Res."},{"issue":"2","key":"10.1016\/j.cbi.2022.110194_bib200","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.etap.2013.06.009","article-title":"Melittin: a lytic peptide with anticancer properties","volume":"36","author":"Gajski","year":"2013","journal-title":"Environ. Toxicol. Pharmacol."},{"issue":"4","key":"10.1016\/j.cbi.2022.110194_bib201","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.3390\/toxins7041126","article-title":"Three valuable peptides from bee and wasp venoms for therapeutic and biotechnological use: melittin, apamin and mastoparan","volume":"7","author":"Moreno","year":"2015","journal-title":"Toxins"},{"issue":"3","key":"10.1016\/j.cbi.2022.110194_bib202","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1517\/13543784.2013.759557","article-title":"Vascular-disrupting agents in oncology","volume":"22","author":"Mita","year":"2013","journal-title":"Expet Opin. Invest. Drugs"},{"issue":"2","key":"10.1016\/j.cbi.2022.110194_bib203","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.bmc.2006.10.020","article-title":"Vascular disrupting agents","volume":"15","author":"Lippert","year":"2007","journal-title":"Bioorg. Med. Chem."},{"issue":"5","key":"10.1016\/j.cbi.2022.110194_bib204","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/molehr\/gan019","article-title":"Antiangiogenic and vascular-disrupting agents in endometriosis: pitfalls and promises","volume":"14","author":"Van Langendonckt","year":"2008","journal-title":"Mol. Hum. Reprod."},{"issue":"4","key":"10.1016\/j.cbi.2022.110194_bib205","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.tibtech.2008.01.002","article-title":"Targeting tumors with peptides from natural sources","volume":"26","author":"Bhutia","year":"2008","journal-title":"Trends Biotechnol."},{"issue":"5","key":"10.1016\/j.cbi.2022.110194_bib206","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrc2628","article-title":"Tumour necrosis factor and cancer","volume":"9","author":"Balkwill","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"34","key":"10.1016\/j.cbi.2022.110194_bib207","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1038\/sj.onc.1209608","article-title":"Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy","volume":"25","author":"Fulda","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.cbi.2022.110194_bib208","series-title":"Encyclopedia of Toxicology","first-page":"287","article-title":"Apoptosis","author":"Brown","year":"2014"},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib209","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/sj.cdd.4401187","article-title":"Apo2L\/TRAIL and its death and decoy receptors","volume":"10","author":"LeBlanc","year":"2003","journal-title":"Cell Death Differ."},{"issue":"53","key":"10.1016\/j.cbi.2022.110194_bib210","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1038\/sj.onc.1207232","article-title":"TRAIL and apoptosis induction by TNF-family death receptors","volume":"22","author":"Wang","year":"2003","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.cbi.2022.110194_bib211","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1111\/j.1742-4658.2010.07590.x","article-title":"Synthetic constrained peptide selectively binds and antagonizes death receptor 5","volume":"277","author":"Vrielink","year":"2010","journal-title":"FEBS J."},{"key":"10.1016\/j.cbi.2022.110194_bib212","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.565841","article-title":"TNF-mediated homeostatic synaptic plasticity: from in\u00a0vitro to in\u00a0vivo models","volume":"14","author":"Heir","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.cbi.2022.110194_bib213","first-page":"11","article-title":"Tumor necrosis factor receptors: pleiotropic signaling complexes and their differential effects","author":"Gough","year":"2020","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.cbi.2022.110194_bib214","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrc780","article-title":"NF-\u03baB in cancer: from innocent bystander to major culprit","volume":"2","author":"Karin","year":"2002","journal-title":"Nat. Rev. Cancer"},{"issue":"53","key":"10.1016\/j.cbi.2022.110194_bib215","doi-asserted-by":"crossref","first-page":"8543","DOI":"10.1038\/sj.onc.1207107","article-title":"A\u00a0decade of caspases","volume":"22","author":"Degterev","year":"2003","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.cbi.2022.110194_bib216","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.etp.2009.06.013","article-title":"Effect of rapeseed peptide on DNA damage and apoptosis in Hela cells","volume":"62","author":"Xue","year":"2010","journal-title":"Exp. Toxicol. Pathol."},{"issue":"6719","key":"10.1016\/j.cbi.2022.110194_bib217","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/17409","article-title":"RGD peptides induce apoptosis by direct caspase-3 activation","volume":"397","author":"Buckley","year":"1999","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib218","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.taap.2012.12.010","article-title":"Plant cyclopeptide RA-V kills human breast cancer cells by inducing mitochondria-mediated apoptosis through blocking PDK1\u2013AKT interaction","volume":"267","author":"Fang","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2022.110194_bib219","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/35037710","article-title":"The biochemistry of apoptosis","volume":"407","author":"Davis","year":"2000","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.cbi.2022.110194_bib220","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.clml.2018.06.015","article-title":"The multiple myeloma drug pipeline\u20142018: a review of small molecules and their therapeutic targets","volume":"18","author":"Abramson","year":"2018","journal-title":"Clin. Lymphoma, Myeloma & Leukemia"},{"issue":"4","key":"10.1016\/j.cbi.2022.110194_bib221","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.3892\/or.2017.5440","article-title":"Tumor-penetrating peptide fused to a pro-apoptotic peptide facilitates effective gastric cancer therapy","volume":"37","author":"Huang","year":"2017","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.cbi.2022.110194_bib222","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0092-8674(00)81871-1","article-title":"p53, the cellular gatekeeper for growth and division","volume":"88","author":"Levine","year":"1997","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib223","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3390\/biom10010128","article-title":"The Bcl-2 family: ancient origins, conserved structures, and divergent mechanisms","volume":"10","author":"Banjara","year":"2020","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.cbi.2022.110194_bib224","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.bbamcr.2010.12.019","article-title":"Molecular biology of Bax and Bak activation and action","volume":"1813","author":"Westphal","year":"2011","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.cbi.2022.110194_bib225","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.3389\/fmicb.2017.02536","article-title":"Marine fungi: a source of potential anticancer compounds","volume":"8","author":"Deshmukh","year":"2018","journal-title":"Front. Microbiol."},{"issue":"2","key":"10.1016\/j.cbi.2022.110194_bib226","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/jcp.10254","article-title":"Cell death regulation by the Bcl-2 protein family in the mitochondria","volume":"195","author":"Tsujimoto","year":"2003","journal-title":"J.\u00a0Cell. Physiol."},{"issue":"6","key":"10.1016\/j.cbi.2022.110194_bib227","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1083\/jcb.200105057","article-title":"VDAC-dependent permeabilization of the outer mitochondrial membrane by superoxide induces rapid and massive cytochrome c release","volume":"155","author":"Madesh","year":"2001","journal-title":"J.\u00a0Cell Biol."},{"issue":"2","key":"10.1016\/j.cbi.2022.110194_bib228","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1083\/jcb.152.2.237","article-title":"Essential role of voltage-dependent anion channel in various forms of apoptosis in mammalian cells","volume":"152","author":"Shimizu","year":"2001","journal-title":"J.\u00a0Cell Biol."},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib229","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrm2308","article-title":"The BCL-2 protein family: opposing activities that mediate cell death","volume":"9","author":"Youle","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib230","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/cdd.2017.186","article-title":"BCL-2 family proteins: changing partners in the dance towards death","volume":"25","author":"Kale","year":"2018","journal-title":"Cell Death Differ."},{"issue":"4","key":"10.1016\/j.cbi.2022.110194_bib231","article-title":"Mechanisms of action of Bcl2 protein","volume":"5","author":"Aisha","year":"2013","journal-title":"Cold Spring Harbor Perspect. Biol."},{"issue":"17","key":"10.1016\/j.cbi.2022.110194_bib232","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1158\/1078-0432.CCR-08-0233","article-title":"TMTP1, a novel tumor-homing peptide specifically targeting metastasis","volume":"14","author":"Yang","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.cbi.2022.110194_bib233","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.bbagen.2009.04.020","article-title":"Induction of apoptosis by Polygonatum odoratum lectin and its molecular mechanisms in murine fibrosarcoma L929 cells","volume":"1790","author":"Liu","year":"2009","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib234","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008890","article-title":"Complementary roles in cancer prevention: protease inhibitor makes the cancer preventive peptide lunasin bioavailable","volume":"5","author":"Hsieh","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.cbi.2022.110194_bib235","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jmb.2006.06.042","article-title":"Activation of the proapoptotic death receptor DR5 by oligomeric peptide and antibody agonists","volume":"361","author":"Li","year":"2006","journal-title":"J.\u00a0Mol. Biol."},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib236","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/sj.cdd.4401185","article-title":"Protein-based therapeutic approaches targeting death receptors","volume":"10","author":"French","year":"2003","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cbi.2022.110194_bib237","series-title":"Cell Survival and Death in Rheumatic Diseases. Kelley's Textbook of Rheumatology","first-page":"382","author":"Elkon","year":"2013"},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib238","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1006\/excr.2000.4840","article-title":"The CD95 (APO-1\/Fas) and the TRAIL (APO-2L) apoptosis systems","volume":"256","author":"Walczak","year":"2000","journal-title":"Exp. Cell Res."},{"issue":"6805","key":"10.1016\/j.cbi.2022.110194_bib239","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/35037710","article-title":"The biochemistry of apoptosis","volume":"407","author":"Hengartner","year":"2000","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.cbi.2022.110194_bib240","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1006\/bbrc.2001.4895","article-title":"Trail-induced apoptosis in Type I leukemic cells is not enhanced by overexpression of bax","volume":"283","author":"Jia","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2022.110194_bib241","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/B978-0-444-52001-2.00042-X","article-title":"Genetics of primary progressive multiple sclerosis","volume":"122","author":"Cree","year":"2014","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.cbi.2022.110194_bib242","series-title":"xPharm: the Comprehensive Pharmacology Reference","first-page":"1","article-title":"Caspase 9","author":"Widmann","year":"2007"},{"issue":"11","key":"10.1016\/j.cbi.2022.110194_bib243","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.1021\/acs.jmedchem.5b02016","article-title":"Amphipathicity determines different cytotoxic mechanisms of lysine-or arginine-rich cationic hydrophobic peptides in cancer cells","volume":"59","author":"Liu","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"issue":"9","key":"10.1016\/j.cbi.2022.110194_bib244","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139578","article-title":"In\u00a0vitro characterization of the rapid cytotoxicity of anticancer peptide HPRP-A2 through membrane destruction and intracellular mechanism against gastric cancer cell lines","volume":"10","author":"Zhao","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.cbi.2022.110194_bib245","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.4155\/fmc-2017-0088","article-title":"LTX-315: a first-in-class oncolytic peptide that reprograms the tumor microenvironment","volume":"9","author":"Sveinbj\u00f8rnsson","year":"2017","journal-title":"Future Med. Chem."},{"issue":"59","key":"10.1016\/j.cbi.2022.110194_bib246","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.21740","article-title":"Venom-based peptide therapy: insights into anti-cancer mechanism","volume":"8","author":"Ma","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.cbi.2022.110194_bib247","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3390\/ph7050545","article-title":"Human antimicrobial peptides and proteins","volume":"7","author":"Wang","year":"2014","journal-title":"Pharmaceuticals"},{"issue":"7","key":"10.1016\/j.cbi.2022.110194_bib248","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1007\/s00018-005-4560-2","article-title":"Host defense peptides as new weapons in cancer treatment","volume":"62","author":"Papo","year":"2005","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.cbi.2022.110194_bib249","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bcp.2016.09.018","article-title":"Antimicrobial peptides (AMPs): ancient compounds that represent novel weapons in the fight against bacteria","volume":"133","author":"Sanchez-Perez","year":"2017","journal-title":"Biochem. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.cbi.2022.110194_bib250","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0005-2736(99)00201-1","article-title":"Structural features of helical antimicrobial peptides: their potential to modulate activity on model membranes and biological cells","volume":"1462","author":"Dathe","year":"1999","journal-title":"Biochim. Biophys. Acta Biomembr."},{"issue":"2","key":"10.1016\/j.cbi.2022.110194_bib251","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0005-2736(01)00429-1","article-title":"General aspects of peptide selectivity towards lipid bilayers and cell membranes studied by variation of the structural parameters of amphipathic helical model peptides","volume":"1558","author":"Dathe","year":"2002","journal-title":"Biochim. Biophys. Acta Biomembr."},{"issue":"D1","key":"10.1016\/j.cbi.2022.110194_bib252","doi-asserted-by":"crossref","first-page":"D1087","DOI":"10.1093\/nar\/gkv1278","article-title":"APD3: the antimicrobial peptide database as a tool for research and education","volume":"44","author":"Wang","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cbi.2022.110194_bib253","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.euprot.2014.05.003","article-title":"The emergence of peptides in the pharmaceutical business: from exploration to exploitation","volume":"4","author":"Uhlig","year":"2014","journal-title":"EuPA Open Proteomics"},{"issue":"28","key":"10.1016\/j.cbi.2022.110194_bib254","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.16743","article-title":"Antimicrobial peptides with selective antitumor mechanisms: prospect for anticancer applications","volume":"8","author":"Deslouches","year":"2017","journal-title":"Oncotarget"},{"issue":"22","key":"10.1016\/j.cbi.2022.110194_bib255","doi-asserted-by":"crossref","first-page":"7609","DOI":"10.1021\/ja8093247","article-title":"Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity","volume":"131","author":"Rathinakumar","year":"2009","journal-title":"J.\u00a0Am. Chem. Soc."},{"issue":"11","key":"10.1016\/j.cbi.2022.110194_bib256","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3390\/toxins10110461","article-title":"Insect antimicrobial peptides, a mini review","volume":"10","author":"Wu","year":"2018","journal-title":"Toxins"},{"issue":"9","key":"10.1016\/j.cbi.2022.110194_bib257","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.bbamem.2006.07.007","article-title":"The human beta-defensin-3, an antibacterial peptide with multiple biological functions","volume":"1758","author":"Dhople","year":"2006","journal-title":"Biochim. Biophys. Acta Biomembr."},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib258","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1124\/pr.55.1.2","article-title":"Mechanisms of antimicrobial peptide action and resistance","volume":"55","author":"Yeaman","year":"2003","journal-title":"Pharmacol. Rev."},{"issue":"2","key":"10.1016\/j.cbi.2022.110194_bib259","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1574-6968.2002.tb11000.x","article-title":"Role of membranes in the activities of antimicrobial cationic peptides","volume":"206","author":"Hancock","year":"2002","journal-title":"FEMS Microbiol. Lett."},{"issue":"11","key":"10.1016\/j.cbi.2022.110194_bib260","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1016\/j.peptides.2006.06.010","article-title":"Antibacterial activity of linear peptides spanning the carboxy-terminal \u03b2-sheet domain of arthropod defensins","volume":"27","author":"Varkey","year":"2006","journal-title":"Peptides"},{"issue":"8","key":"10.1016\/j.cbi.2022.110194_bib261","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2217\/imt-2020-0312","article-title":"Antimicrobial\/anticancer peptides: bioactive molecules and therapeutic agents","volume":"13","author":"Kardani","year":"2021","journal-title":"Immunotherapy"},{"key":"10.1016\/j.cbi.2022.110194_bib262","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044351","article-title":"Antitumor and angiostatic activities of the antimicrobial peptide dermaseptin B2","volume":"7","author":"van Zoggel","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2022.110194_bib263","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.omto.2019.12.001","article-title":"In\u00a0vitro and MD simulation study to explore physicochemical parameters for antibacterial peptide to become potent anticancer peptide","volume":"16","author":"Ma","year":"2020","journal-title":"Molecular Therapy Oncolytics"},{"issue":"22","key":"10.1016\/j.cbi.2022.110194_bib264","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1007\/s00018-005-5373-z","volume":"62","author":"Gifford","year":"2005","journal-title":"Lactoferricin. Cellular Molecular Life Sci."},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-34684-1","article-title":"Design of a novel cell-permeable chimeric peptide to promote wound healing","volume":"8","author":"Horn","year":"2018","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.cbi.2022.110194_bib266","doi-asserted-by":"crossref","first-page":"103","DOI":"10.15171\/bi.2015.10","article-title":"Cell-penetrating peptides and their analogues as novel nanocarriers for drug delivery","volume":"5","author":"Jafari","year":"2015","journal-title":"Bioimpacts"},{"issue":"9","key":"10.1016\/j.cbi.2022.110194_bib267","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.molmed.2015.06.005","article-title":"Cell-penetrating peptides: strategies for anticancer treatment","volume":"21","author":"Raucher","year":"2015","journal-title":"Trends Mol. Med."},{"issue":"9","key":"10.1016\/j.cbi.2022.110194_bib268","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3390\/ph5090991","article-title":"Applications of cell-penetrating peptides for tumor targeting and future cancer therapies","volume":"5","author":"Regberg","year":"2012","journal-title":"Pharmaceuticals"},{"issue":"13","key":"10.1016\/j.cbi.2022.110194_bib269","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1039\/b719950c","article-title":"Cell-penetrating peptides as delivery vehicles for biology and medicine","volume":"6","author":"Stewart","year":"2008","journal-title":"Org. Biomol. Chem."},{"issue":"2","key":"10.1016\/j.cbi.2022.110194_bib270","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2174\/1389203033487306","article-title":"TAT peptide internalization: seeking the mechanism of entry","volume":"4","author":"Vives","year":"2003","journal-title":"Curr. Protein Pept. Sci."},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib271","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1074\/jbc.M209548200","article-title":"Cell-penetrating peptides: a reevaluation of the mechanism of cellular uptake","volume":"278","author":"Richard","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"issue":"3","key":"10.1016\/j.cbi.2022.110194_bib272","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nrmicro1098","article-title":"Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?","volume":"3","author":"Brogden","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.cbi.2022.110194_bib273","series-title":"Fluorescent Labeling of Proteins. Single Molecule Analysis","first-page":"115","author":"Modesti","year":"2018"},{"issue":"2","key":"10.1016\/j.cbi.2022.110194_bib274","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1476-5381.2009.00057.x","article-title":"Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics","volume":"157","author":"Heitz","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cbi.2022.110194_bib275","series-title":"Cell-penetrating Peptides (CPPs): an Overview of Applications for Improving the Potential of Nanotherapeutics","author":"Desale","year":"2021"},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib276","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/biohorizons\/hzp001","article-title":"Cell-penetrating peptides and their therapeutic applications","volume":"2","author":"Sebbage","year":"2009","journal-title":"Bioscience Horizons"},{"issue":"5877","key":"10.1016\/j.cbi.2022.110194_bib277","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1126\/science.1152622","article-title":"Toward an AIDS vaccine","volume":"320","author":"Walker","year":"2008","journal-title":"science"},{"issue":"3","key":"10.1016\/j.cbi.2022.110194_bib278","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1600-0854.2011.01286.x","article-title":"The ins and outs of HIV-1 Tat","volume":"13","author":"Debaisieux","year":"2012","journal-title":"Traffic"},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib279","doi-asserted-by":"crossref","first-page":"6093","DOI":"10.1038\/s41598-017-06381-y","article-title":"Tumor-targeted delivery of siRNA using fatty acyl-CGKRK peptide conjugates","volume":"7","author":"Sharma","year":"2017","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.cbi.2022.110194_bib280","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.nano.2017.04.004","article-title":"Cell-penetrating peptide CGKRK mediates efficient and widespread targeting of bladder mucosa following focal injury","volume":"13","author":"Griffin","year":"2017","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.cbi.2022.110194_bib281","series-title":"Encyclopedic Reference of Cancer","author":"Schwab","year":"2001"},{"issue":"5665","key":"10.1016\/j.cbi.2022.110194_bib282","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1126\/science.1095833","article-title":"Drug delivery systems: entering the mainstream","volume":"303","author":"Allen","year":"2004","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.cbi.2022.110194_bib283","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrc724","article-title":"Specialization of tumour vasculature","volume":"2","author":"Ejcc","year":"2002","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.cbi.2022.110194_bib284","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035187","article-title":"TumorHoPe: a database of tumor homing peptides","volume":"7","author":"Kapoor","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.cbi.2022.110194_bib285","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1039\/C7MD00638A","article-title":"Development of a peptide-based bifunctional chelator conjugated to a cytotoxic drug for the treatment of melanotic melanoma","volume":"9","author":"Gaonkar","year":"2018","journal-title":"Med. Chem. Comm."},{"issue":"4","key":"10.1016\/j.cbi.2022.110194_bib286","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1039\/C8MD00565F","article-title":"Design of 5-fluorouracil (5-FU) loaded, folate conjugated peptide linked nanoparticles, a potential new drug carrier for selective targeting of tumor cells","volume":"10","author":"Kazi","year":"2019","journal-title":"Med. Chem. Comm."},{"issue":"2","key":"10.1016\/j.cbi.2022.110194_bib287","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1021\/nl404391r","article-title":"Passive versus active tumor targeting using RGD-and NGR-modified polymeric nanomedicines","volume":"14","author":"Kunjachan","year":"2014","journal-title":"Nano Lett."},{"issue":"19","key":"10.1016\/j.cbi.2022.110194_bib288","doi-asserted-by":"crossref","first-page":"5985","DOI":"10.1073\/pnas.81.19.5985","article-title":"Variants of the cell recognition site of fibronectin that retain attachment-promoting activity","volume":"81","author":"Pierschbacher","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4826","key":"10.1016\/j.cbi.2022.110194_bib289","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1126\/science.2821619","article-title":"New perspectives in cell adhesion: RGD and integrins","volume":"238","author":"Ruoslahti","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.cbi.2022.110194_bib290","series-title":"Nanoparticles in Translational Science and Medicine","author":"Villaverde","year":"2011"},{"issue":"10","key":"10.1016\/j.cbi.2022.110194_bib291","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2174\/187152010794728639","article-title":"Cilengitide: the first antiangiogenic small molecule drug candidate","volume":"10","author":"Carlos","year":"2010","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"27","key":"10.1016\/j.cbi.2022.110194_bib292","doi-asserted-by":"crossref","first-page":"20205","DOI":"10.1016\/S0021-9258(20)80715-7","article-title":"Selection of peptides binding to the alpha 5 beta 1 integrin from phage display library","volume":"268","author":"Koivunen","year":"1993","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cbi.2022.110194_bib293","series-title":"Protein and Peptide Nanoparticles for Drug Delivery","author":"Donev","year":"2015"},{"issue":"5","key":"10.1016\/j.cbi.2022.110194_bib294","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/8676","article-title":"A\u00a0soybean cDNA encoding a chromatin-binding peptide inhibits mitosis of mammalian cells","volume":"17","author":"Galvez","year":"1999","journal-title":"Nat. Biotechnol."},{"issue":"17","key":"10.1016\/j.cbi.2022.110194_bib295","doi-asserted-by":"crossref","first-page":"7734","DOI":"10.18632\/oncotarget.2301","article-title":"Amphipathic tail-anchoring peptide is a promising therapeutic agent for prostate cancer treatment","volume":"5","author":"De","year":"2014","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib296","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1158\/1535-7163.MCT-14-0366","article-title":"Tumor-penetrating iRGD peptide inhibits metastasis","volume":"14","author":"Sugahara","year":"2015","journal-title":"Mol. Cancer Therapeut."},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib297","first-page":"36","article-title":"Development of NGR peptide-based agents for tumor imaging","volume":"1","author":"Wang","year":"2011","journal-title":"Am. J. Nucl. Med. Mol. Imaging"},{"issue":"7","key":"10.1016\/j.cbi.2022.110194_bib298","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1182\/blood-2008-04-150862","article-title":"The neovasculature homing motif NGR: more than meets the eye","volume":"112","author":"Corti","year":"2008","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.cbi.2022.110194_bib299","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178632","article-title":"NGR-peptide\u2212 drug conjugates with dual targeting properties","volume":"12","author":"Enyedi","year":"2017","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.cbi.2022.110194_bib300","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0024-3205(84)90302-3","article-title":"Synthesis of tritium labeled Ac-[Nle4, D-Phe7]-\u03b1-MSH4\u2212 11-NH2: a superpotent melanotropin with prolonged biological activity","volume":"34","author":"Wilkes","year":"1984","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.cbi.2022.110194_bib301","doi-asserted-by":"crossref","first-page":"481","DOI":"10.7150\/thno.4024","article-title":"Radiolabeled peptides: valuable tools for the detection and treatment of cancer","volume":"2","author":"Fani","year":"2012","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.cbi.2022.110194_bib302","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/annonc\/mdm111","article-title":"Targeted therapy in nuclear medicine\u2014current status and future prospects","volume":"18","author":"Oyen","year":"2007","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.cbi.2022.110194_bib303","first-page":"47","article-title":"Peptide receptor radionuclide therapy: an overview","volume":"30","author":"Dash","year":"2015","journal-title":"Cancer Biother. Rad."},{"key":"10.1016\/j.cbi.2022.110194_bib304","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3389\/fonc.2013.00247","article-title":"Peptides in receptor-mediated radiotherapy: from design to the clinical application in cancers","volume":"3","author":"Lozza","year":"2013","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cbi.2022.110194_bib305","unstructured":"Xiao Q, Feng B, Luo W, Sun L. (Cytotoxic Peptide Conjugates: Anticancer Therapeutic Strategies)."},{"issue":"17\u201318","key":"10.1016\/j.cbi.2022.110194_bib306","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.drudis.2013.05.011","article-title":"Future directions for peptide therapeutics development","volume":"18","author":"Kaspar","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.cbi.2022.110194_bib307","series-title":"Women and Health","first-page":"271","article-title":"Chapter 18 - endometriosis","author":"Holt","year":"2013"},{"issue":"3","key":"10.1016\/j.cbi.2022.110194_bib308","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/bju.14168","article-title":"Are all gonadotrophin-releasing hormone agonists equivalent for the treatment of prostate cancer? A systematic review","volume":"122","author":"Bolton","year":"2018","journal-title":"BJU Int."},{"key":"10.1016\/j.cbi.2022.110194_bib309","series-title":"Handbook of Hormones","article-title":"Chapter 3 - gonadotropin-releasing hormone","author":"Ando","year":"2016"},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib310","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10989-016-9534-8","article-title":"Peptides as \u2018drugs\u2019: the journey so far","volume":"23","author":"Sachdeva","year":"2017","journal-title":"Int. J. Pept. Res. Therapeut."},{"key":"10.1016\/j.cbi.2022.110194_bib311","series-title":"Somatostatin analogs in the gastrointestinal tract. Handbook of Biologically Active Peptides","first-page":"1131","author":"Harris","year":"2006"},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib312","article-title":"Preoperative somatostatin analogues in patients with newly-diagnosed acromegaly: a systematic review and meta-analysis of comparative studies","volume":"9","author":"Yang","year":"2019","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.cbi.2022.110194_bib313","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/jnci\/94.11.805","article-title":"Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going?","volume":"94","author":"Parmiani","year":"2002","journal-title":"J.\u00a0Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib314","doi-asserted-by":"crossref","first-page":"394","DOI":"10.4049\/jimmunol.173.1.394","article-title":"Generation of peptide mimics of the epitope recognized by trastuzumab on the oncogenic protein Her-2\/neu","volume":"173","author":"Riemer","year":"2004","journal-title":"J.\u00a0Immunol."},{"issue":"6","key":"10.1016\/j.cbi.2022.110194_bib315","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1586\/erv.12.33","article-title":"Toxicity profiles of HER2\/neu peptide anticancer vaccines: the picture from Phase\/I and II clinical trials","volume":"11","author":"Baxevanis","year":"2012","journal-title":"Expet Rev. Vaccine"},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib316","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ctrv.2007.07.017","article-title":"Peptide-based radiopharmaceuticals and cytotoxic conjugates: potential tools against cancer","volume":"34","author":"Okarvi","year":"2008","journal-title":"Cancer Treat Rev."},{"issue":"3","key":"10.1016\/j.cbi.2022.110194_bib317","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.nucmedbio.2009.12.006","article-title":"Synthesis and evaluation of a technetium-99m labeled cytotoxic bombesin peptide conjugate for targeting bombesin receptor-expressing tumors","volume":"37","author":"Okarvi","year":"2010","journal-title":"Nucl. Med."},{"key":"10.1016\/j.cbi.2022.110194_bib318","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cellimm.2017.10.015","article-title":"The paradox of Th17 cell functions in tumor immunity","volume":"322","author":"Asadzadeh","year":"2017","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.cbi.2022.110194_bib319","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jprot.2016.03.048","article-title":"Bioactive peptides in plant-derived foodstuffs","volume":"147","author":"Maestri","year":"2016","journal-title":"J.\u00a0Proteonomics"},{"issue":"3","key":"10.1016\/j.cbi.2022.110194_bib320","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1021\/nn4057269","article-title":"Cell-penetrating peptides: design, synthesis, and applications","volume":"8","author":"Copolovici","year":"2014","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.cbi.2022.110194_bib321","doi-asserted-by":"crossref","DOI":"10.4172\/2169-0138.1000138","article-title":"Design and modification of anticancer peptides","volume":"5","author":"Hu","year":"2016","journal-title":"Drug Des"},{"issue":"49","key":"10.1016\/j.cbi.2022.110194_bib322","doi-asserted-by":"crossref","first-page":"47891","DOI":"10.1074\/jbc.M207500200","article-title":"Structure-activity relationships of linear and cyclic peptides containing the NGR tumor-homing motif","volume":"277","author":"Colombo","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"issue":"12","key":"10.1016\/j.cbi.2022.110194_bib323","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3390\/md18120650","article-title":"Improved stability and activity of a marine peptide-N6NH2 against edwardsiella tarda and its preliminary application in fish","volume":"18","author":"Han","year":"2020","journal-title":"Mar. Drugs"},{"issue":"suppl_1","key":"10.1016\/j.cbi.2022.110194_bib324","doi-asserted-by":"crossref","first-page":"D590","DOI":"10.1093\/nar\/gkh025","article-title":"APD: the antimicrobial peptide database","volume":"32","author":"Wang","year":"2004","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"10.1016\/j.cbi.2022.110194_bib325","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1529\/biophysj.108.135517","article-title":"Efficiency of histidine-associating compounds for blocking the Alzheimer's A\u03b2 channel activity and cytotoxicity","volume":"95","author":"Arispe","year":"2008","journal-title":"Biophys. J."},{"key":"10.1016\/j.cbi.2022.110194_bib326","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/978-1-4939-7201-2_17","article-title":"In silico design of anticancer peptides","author":"Kumar","year":"2017","journal-title":"Proteomics for Drug Discovery"},{"issue":"7","key":"10.1016\/j.cbi.2022.110194_bib327","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/psc.629","article-title":"Structural studies and model membrane interactions of two peptides derived from bovine lactoferricin","volume":"11","author":"Nguyen","year":"2005","journal-title":"J.\u00a0Pept. Sci."},{"issue":"7","key":"10.1016\/j.cbi.2022.110194_bib328","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.200004","article-title":"Anti-cancer peptides: classification, mechanism of action, reconstruction and modification","volume":"10","author":"Xie","year":"2020","journal-title":"Open Biology"},{"key":"10.1016\/j.cbi.2022.110194_bib329","first-page":"88","article-title":"Unnatural amino acids: better than the real things? F1000","volume":"1","author":"Minnihan","year":"2009","journal-title":"Biol Rep"},{"issue":"30","key":"10.1016\/j.cbi.2022.110194_bib330","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1021\/acs.biochem.7b00536","article-title":"Residue-specific peptide modification: a chemist's guide","volume":"56","author":"deGruyter","year":"2017","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.cbi.2022.110194_bib331","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.chembiol.2010.02.008","article-title":"Protein chemical modification on endogenous amino acids","volume":"17","author":"Basl\u00e9","year":"2010","journal-title":"Chem. Biol."},{"key":"10.1016\/j.cbi.2022.110194_bib332","series-title":"Oral Delivery of Insulin","first-page":"113","article-title":"3 - oral insulin delivery \u2013 challenges and strategies","author":"Sonia","year":"2014"},{"key":"10.1016\/j.cbi.2022.110194_bib333","series-title":"Comprehensive Medicinal Chemistry II","first-page":"573","article-title":"2.14 - peptide and protein drugs: issues and solutions","author":"Nestor","year":"2007"},{"key":"10.1016\/j.cbi.2022.110194_bib334","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2147\/CMAR.S232708","article-title":"Research progress evaluating the function and mechanism of anti-tumor peptides","volume":"12","author":"Pan","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.cbi.2022.110194_bib335","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3389\/fchem.2020.00447","article-title":"Methodologies for backbone macrocyclic peptide synthesis compatible with screening technologies","volume":"8","author":"Shinbara","year":"2020","journal-title":"Front. Chem."},{"issue":"16","key":"10.1016\/j.cbi.2022.110194_bib336","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1021\/bi00016a002","article-title":"Thermodynamic analysis of the structural stability of the tetrameric oligomerization domain of p53 tumor suppressor","volume":"34","author":"Johnson","year":"1995","journal-title":"Biochemistry"},{"issue":"10","key":"10.1016\/j.cbi.2022.110194_bib337","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.addr.2012.09.039","article-title":"Fusion protein linkers: property, design and functionality","volume":"65","author":"Chen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.cbi.2022.110194_bib338","series-title":"Comprehensive Chirality","first-page":"288","article-title":"9.12 industrial applications of biocatalytic hydrolysis (esters, amides, epoxides, nitriles) and biocatalytic dynamic kinetic resolution","author":"Patel","year":"2012"},{"key":"10.1016\/j.cbi.2022.110194_bib339","series-title":"Chimeric Genes, Proteins\u2606. Reference Module in Life Sciences","author":"Strohl","year":"2017"},{"key":"10.1016\/j.cbi.2022.110194_bib340","series-title":"Brenner's Encyclopedia of Genetics","author":"Maloy","year":"2013"},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib341","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0006-291X(87)90726-1","article-title":"Chimeric peptides as a vehicle for peptide pharmaceutical delivery through the blood-brain barrier","volume":"146","author":"Pardridge","year":"1987","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.cbi.2022.110194_bib342","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1021\/acs.chemrev.7b00305","article-title":"Electrostatic interactions in protein structure, folding, binding, and condensation","volume":"118","author":"Zhou","year":"2018","journal-title":"Chem. Rev."},{"issue":"1602","key":"10.1016\/j.cbi.2022.110194_bib343","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1098\/rstb.2012.0013","article-title":"Why nature chose phosphate to modify proteins","volume":"367","author":"Hunter","year":"2012","journal-title":"Phil. Trans. Biol. Sci."},{"key":"10.1016\/j.cbi.2022.110194_bib344","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.steroids.2018.12.003","article-title":"Cholesterol biosensors: a review","volume":"143","author":"Narwal","year":"2019","journal-title":"Steroids"},{"issue":"12","key":"10.1016\/j.cbi.2022.110194_bib345","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1016\/j.jmb.2019.04.026","article-title":"Alpha-synuclein is a target of Fic-mediated adenylylation\/AMPylation: possible implications for Parkinson's disease","volume":"431","author":"Sanyal","year":"2019","journal-title":"J.\u00a0Mol. Biol."},{"issue":"10","key":"10.1016\/j.cbi.2022.110194_bib346","first-page":"857","article-title":"Editorial (thematic issue: roles of sumoylation and phosphorylation in normal physiology and human diseases)","volume":"16","author":"Li Djcmm","year":"2016","journal-title":"Curr. Mol. Med."},{"issue":"3","key":"10.1016\/j.cbi.2022.110194_bib347","first-page":"337","article-title":"PEGylation in anti-cancer therapy: an overview","volume":"11","author":"Mishra","year":"2016","journal-title":"Asian J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib348","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2174\/138920012798356934","article-title":"PEGylation of proteins and liposomes: a powerful and flexible strategy to improve the drug delivery","volume":"13","author":"Milla","year":"2012","journal-title":"Curr. Drug Metabol."},{"issue":"4","key":"10.1016\/j.cbi.2022.110194_bib349","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1517\/17425247.5.4.371","article-title":"Advances in PEGylation of important biotech molecules: delivery aspects","volume":"5","author":"Ryan","year":"2008","journal-title":"Expet Opin. Drug Deliv."},{"issue":"39","key":"10.1016\/j.cbi.2022.110194_bib350","doi-asserted-by":"crossref","first-page":"9278","DOI":"10.1039\/C6OB01815G","article-title":"Polymeric prodrug combination to exploit the therapeutic potential of antimicrobial peptides against cancer cells","volume":"14","author":"Kelly","year":"2016","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.cbi.2022.110194_bib351","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.colsurfb.2016.08.005","article-title":"Targeting cancer cells via tumor-homing peptide CREKA functional PEG nanoparticles","volume":"147","author":"Okur","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"16","key":"10.1016\/j.cbi.2022.110194_bib352","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.4155\/fmc.14.125","article-title":"PEGylation and its impact on the design of new protein-based medicines","volume":"6","author":"Ginn","year":"2014","journal-title":"Future Med. Chem."},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib353","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejcb.2005.08.010","article-title":"Characterization of the oligosaccharide component of \u03b13\u03b21 integrin from human bladder carcinoma cell line T24 and its role in adhesion and migration","volume":"85","author":"Poche\u0107","year":"2006","journal-title":"Eur. J. Cell Biol."},{"issue":"9","key":"10.1016\/j.cbi.2022.110194_bib354","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/glycob\/cww023","article-title":"Plant protein glycosylation","volume":"26","author":"Strasser","year":"2016","journal-title":"Glycobiology"},{"issue":"12","key":"10.1016\/j.cbi.2022.110194_bib355","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1016\/j.bbamem.2011.07.009","article-title":"Protein palmitoylation and subcellular trafficking","volume":"1808","author":"Aicart-Ramos","year":"2011","journal-title":"Biochim. Biophys. Acta Biomembr."},{"issue":"2","key":"10.1016\/j.cbi.2022.110194_bib356","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1152\/physrev.00032.2014","article-title":"The physiology of protein S-acylation","volume":"95","author":"Chamberlain","year":"2015","journal-title":"Physiol. Rev."},{"issue":"10","key":"10.1016\/j.cbi.2022.110194_bib357","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1021\/ar8000603","article-title":"N-methylation of peptides: a new perspective in medicinal chemistry","volume":"41","author":"Chatterjee","year":"2008","journal-title":"Acc. Chem. Res."},{"issue":"2","key":"10.1016\/j.cbi.2022.110194_bib358","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF00928431","article-title":"Cyclosporin a and C","volume":"3","author":"Dreyfuss","year":"1976","journal-title":"Eur. J. Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.cbi.2022.110194_bib359","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev.micro.58.030603.123615","article-title":"Biosynthesis of nonribosomal peptides","volume":"58","author":"Finking","year":"2004","journal-title":"Annu. Rev. Microbiol."},{"issue":"2","key":"10.1016\/j.cbi.2022.110194_bib360","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1021\/cr0301191","article-title":"Molecular mechanisms underlying nonribosomal peptide synthesis: approaches to new antibiotics","volume":"105","author":"Sieber","year":"2005","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib361","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1021\/jo00149a016","article-title":"Synthesis of 9-fluorenylmethyloxycarbonyl-protected N-alkyl amino acids by reduction of oxazolidinones","volume":"48","author":"Freidinger","year":"1983","journal-title":"J.\u00a0Org. Chem."},{"issue":"6","key":"10.1016\/j.cbi.2022.110194_bib362","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3390\/md19060311","article-title":"Improvement on permeability of cyclic peptide\/peptidomimetic: backbone N-methylation as A useful tool","volume":"19","author":"Li","year":"2021","journal-title":"Mar. Drugs"},{"issue":"8","key":"10.1016\/j.cbi.2022.110194_bib363","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1128\/AAC.48.8.3127-3129.2004","article-title":"In\u00a0vitro activity and potency of an intravenously injected antimicrobial peptide and its DL amino acid analog in mice infected with bacteria","volume":"48","author":"Braunstein","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.cbi.2022.110194_bib364","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1128\/AAC.06335-11","article-title":"Pegylation of antimicrobial peptides maintains the active peptide conformation, model membrane interactions, and antimicrobial activity while improving lung tissue biocompatibility following airway delivery","volume":"56","author":"Morris","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.cbi.2022.110194_bib365","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1007\/s12272-013-0112-8","article-title":"Design of potent, non-toxic anticancer peptides based on the structure of the antimicrobial peptide, temporin-1CEa","volume":"36","author":"Yang","year":"2013","journal-title":"Arch Pharm. Res. (Seoul)"},{"issue":"7","key":"10.1016\/j.cbi.2022.110194_bib366","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/anie.198205121","article-title":"Conformation and biological activity of cyclic peptides","volume":"21","author":"Kessler","year":"1982","journal-title":"Angew. Chem."},{"issue":"3","key":"10.1016\/j.cbi.2022.110194_bib367","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0024-3205(82)90578-1","article-title":"Conformational restrictions of biologically active peptides via amino acid side chain groups","volume":"31","author":"Hruby","year":"1982","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.cbi.2022.110194_bib368","first-page":"956","article-title":"Synthesis of linear and cyclic disulfide heptapeptides of Longicalycinin A and evaluation of toxicity on cancerous cells HepG2 and HT-29","volume":"17","author":"HoushdarTehrani","year":"2018","journal-title":"Iran. J. Pharm. Res. (IJPR)"},{"issue":"38","key":"10.1016\/j.cbi.2022.110194_bib369","doi-asserted-by":"crossref","first-page":"12612","DOI":"10.1021\/bi960835f","article-title":"Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes","volume":"35","author":"Dathe","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.cbi.2022.110194_bib370","first-page":"3","article-title":"Peptides as drug candidates: limitations and recent development perspectives","volume":"1","author":"Haggag","year":"2018","journal-title":"Biomed. J."},{"issue":"3","key":"10.1016\/j.cbi.2022.110194_bib371","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1021\/acs.orglett.7b03363","article-title":"Improving the cell permeability of polar cyclic peptides by replacing residues with alkylated amino acids, asparagines, and d-Amino Acids","volume":"20","author":"Buckton","year":"2018","journal-title":"Org. Lett."},{"issue":"4","key":"10.1016\/j.cbi.2022.110194_bib372","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2174\/1568026615666150108125040","article-title":"Highlights in peptide nanoparticle carriers intended to oral diseases","volume":"15","author":"Benergossi","year":"2015","journal-title":"Curr. Top. Med. Chem."},{"issue":"3","key":"10.1016\/j.cbi.2022.110194_bib373","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/bip.20417","article-title":"Determination of intrinsic hydrophilicity\/hydrophobicity of amino acid side chains in peptides in the absence of nearest-neighbor or conformational effects","volume":"84","author":"Kovacs","year":"2006","journal-title":"Peptide Science"},{"issue":"4","key":"10.1016\/j.cbi.2022.110194_bib374","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1128\/AAC.00925-06","article-title":"Role of peptide hydrophobicity in the mechanism of action of \u03b1-helical antimicrobial peptides","volume":"51","author":"Chen","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"issue":"13","key":"10.1016\/j.cbi.2022.110194_bib375","doi-asserted-by":"crossref","first-page":"12316","DOI":"10.1074\/jbc.M413406200","article-title":"Rational design of \u03b1-helical antimicrobial peptides with enhanced activities and specificity\/therapeutic index","volume":"280","author":"Chen","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"issue":"25","key":"10.1016\/j.cbi.2022.110194_bib376","doi-asserted-by":"crossref","first-page":"22918","DOI":"10.1074\/jbc.M301777200","article-title":"A\u00a0novel method to measure self-association of small amphipathic molecules: temperature profiling in reversed-phase chromatography","volume":"278","author":"Lee","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"issue":"1","key":"10.1016\/j.cbi.2022.110194_bib377","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10799890902732823","article-title":"Receptor-mediated tumor targeting with radiopeptides: Part 1. General principles and methods","volume":"29","author":"Eberle","year":"2009","journal-title":"J.\u00a0Recept. Signal Transduction"},{"issue":"10","key":"10.1016\/j.cbi.2022.110194_bib378","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.3390\/molecules24101973","article-title":"ACPred: a computational tool for the prediction and analysis of anticancer peptides","volume":"24","author":"Schaduangrat","year":"2019","journal-title":"Molecules"},{"issue":"13","key":"10.1016\/j.cbi.2022.110194_bib379","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/cmdc.201800204","article-title":"Designing anticancer peptides by constructive machine learning","volume":"13","author":"Grisoni","year":"2018","journal-title":"ChemMedChem"},{"issue":"D1","key":"10.1016\/j.cbi.2022.110194_bib380","doi-asserted-by":"crossref","first-page":"D837","DOI":"10.1093\/nar\/gku892","article-title":"CancerPPD: a database of anticancer peptides and proteins","volume":"43","author":"Tyagi","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"suppl_1","key":"10.1016\/j.cbi.2022.110194_bib381","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkn823","article-title":"APD2: the updated antimicrobial peptide database and its application in peptide design","volume":"37","author":"Wang","year":"2009","journal-title":"Nucleic Acids Res."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279722003994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279722003994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:17:24Z","timestamp":1757859444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279722003994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":379,"alternative-id":["S0009279722003994"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2022.110194","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticancer peptides mechanisms, simple and complex","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2022.110194","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110194"}}